Elutia (ELUT) Share-based Compensation (2019 - 2026)
Elutia (ELUT) reported Share-based Compensation of $931000.0 for Q1 2026, down 23.12% on a YoY basis from $1.2 million in Q1 2025, and down 1.69% sequentially from $947000.0 in Q4 2025.
Elutia (ELUT) Share-based Compensation (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Share-based Compensation data on file, last reported at $931000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 23.12% year-over-year to $931000.0; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (down 21.41% YoY), and the FY2025 full-year result was $4.4 million, up 37.41% from the prior year.
- Share-based Compensation declined to $931000.0 in Q1 2026, from $947000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.7 million in Q2 2024 to a low of $6000.0 in Q1 2024.
- A 5-year average of $1.1 million and a median of $947000.0 in 2025 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation slumped 99.08% in 2024 and soared 20083.33% in 2025, its largest moves.
- Tracing ELUT's Share-based Compensation over 5 years: stood at $893000.0 in 2022, then surged by 170.77% to $2.4 million in 2023, then tumbled by 92.68% to $177000.0 in 2024, then jumped by 435.03% to $947000.0 in 2025, then dropped by 1.69% to $931000.0 in 2026.
- Business Quant data shows ELUT's Share-based Compensation at $931000.0 in Q1 2026, $947000.0 in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | 931,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 931,000.00 |
| Mar 31, 2026 | 931,000.00 |
| Dec 31, 2025 | 947,000.00 |
| Dec 31, 2025 | 947,000.00 |
| Sep 30, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 177,000.00 |
| Dec 31, 2024 | 177,000.00 |
| Sep 30, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 2.42 Mn |
| Dec 31, 2023 | 2.42 Mn |